Mahamaya Lifesciences Limited (MAHALIFE)
Market Closed
11 Aug, 22:00
MSE MSE Primary ₹
181. 00
+1.25
+0.6954%
₹
3.81B Market Cap
- P/E Ratio
- Div Yield
43,200 Volume
- Eps
₹ 179.75
Previous Close Want to track MAHALIFE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Mahamaya Lifesciences Limited (MAHALIFE) Statistics
Valuation metrics
Market Cap 3.81B
Enterprise value 4.06B
Trailing P/E (ttm) 19.45
Forward P/E -
PEG ratio -
Price/Sales (ttm) 1.15
Price/Book (mrq) 4.99
Enterprise Value/Revenue 1.24
Enterprise Value/EBITDA 12.12
Overview
Shares outstanding 23.41M
Float 5.9M
Shares short -
% Held by insiders 0.81%
% Held by institutions 0.05%
Average volume (10 days) 12.72K
Average volume (90 days) 34.56K
Price summary
52-Week low 111
52-Week high 205.05
Beta -
50-Day moving average 169.32
200-Day moving average 167.01
Financials
Fiscal year
Fiscal year ends 31 Mar 2026
Most recent quarter (mrq) 30 Jun 2025
Profitability
Profit margin 0.05%
Operating margin 0.1%
Operational effectiveness
Return on assets 0.08%
Return on equity 0.19%
Income Statement
Revenue (ttm) 3.29B
Revenue per share (ttm) 165.8
Quarterly revenue growth (yoy) 0.41%
Gross profit (ttm) 540.34M
EBITDA 342.59M
Net income to common (ttm) 165.23M
Diluted EPS (ttm) 8.33
Quarterly earnings growth (yoy) 0.51%
Balance Sheet
Total cash (mrq) 393.99M
Total cash per share (mrq) 17.99
Total debt (mrq) 907.37M
Total Debt/Equity (mrq) 74.42
Current ratio (mrq) 1.46%
Book value per share (mrq) 32.46
Cash Flow
Cash flow statement -295.24M
Levered free cash flow (LFCF) -574.17M
